摘要
随着脑血管影像技术的普及,未破裂颅内动脉瘤(UIA)临床检出率越来越高。UIA破裂风险低,但是一旦破裂,严重影响人类健康。UIA治疗存在较大争议,引起临床广泛关注。中华医学会神经外科学分会、中国卒中学会脑血管外科分会、国家神经系统疾病医学中心与国家神经系统疾病临床研究中心联合制订《中国未破裂颅内动脉瘤临床管理指南(2024版)》,该指南采用模块化形式,突出推荐意见,并指出当前研究不足及未来研究方向,从UIA流行病学、人群筛查、临床影像诊断、破裂风险评估、治疗决策及选择,术后随访及长期管理等方面提供了全面的临床管理意见。将证据来源分为中国人群和其他人群,有助于指导国内临床实践。
With the popularization of cerebrovascular imaging technology,the clinical detection rate of unruptured intracranial aneurysm(UIA)is increasing.UIA has a low risk of rupture,but once ruptured,it can seriously affect human health.The treatment of UIA is highly controversial and has attracted widespread clinical attention.The Society of Neurosurgery of the Chinese Medical Association,the Society of Cerebrovascular Surgery of the Chinese Stroke Association,the National Center for Neurological Diseases,and the National Center for Clinical Research on Neurological Diseases jointly formulate"Chinese guideline for the clinical management of patients with unruptured intracranial aneurysm management(2024)",which adopts a modular format,highlighting management recommendations and indicating current research deficiencies and future research directions.It provides comprehensive clinical management recommendations on UIA epidemiology,population screening,clinical imaging and diagnosis,rupture risk assessment,treatment decisions and choices,postoperative follow-up,and long-term management.The evidence sources are divided into the Chinese population and other populations,which helps guide clinical practice in China.
作者
赵兵
刘清源
王硕
Zhao Bing;Liu Qingyuan;Wang Shuo(Department of Neurosurgery,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China)
出处
《中华医学杂志》
CAS
CSCD
北大核心
2024年第21期1903-1906,共4页
National Medical Journal of China
基金
国家重点研发计划(2021YFC2501100)
关键词
颅内动脉瘤
指南
破裂风险
治疗
临床管理
Intracranial aneurysm
Guideline
Risk of rupture
Treatment
Management
